Showing results (81-90 of 294) with videos related to
Sort By:
Pageof 30
Gut|June 16, 2022
Current therapies and new developments in NASHJean-François Dufour, Quentin M Anstee, Elisabetta Bugianesi, et al.Journal of Patient-Reported Outcomes|July 1, 2025
NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosisLynda C Doward, Matthew Breckons, Maria-Magdalena Balp, et al.Journal of Hepatology|October 10, 2022
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and consJuan M Pericàs, Frank Tacke, Quentin M Anstee, et al.Journal of Clinical Gastroenterology|October 17, 2022
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic SteatohepatitisIra M Jacobson, Vincent Wai-Sun Wong, Laurent Castera, et al.Alimentary Pharmacology & Therapeutics|September 23, 2025
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients With MASHLouise Maymann Nitze, Vlad Ratziu, Arun J Sanyal, et al.Plos One|September 11, 2020
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysisJenny Lee, Yasaman Vali, Jérôme Boursier, et al.Psychiatric Genetics|March 28, 2017
Genetic variation in GABRβ1 and the risk for developing alcohol dependenceWilliam A McCabe, Michael J Way, Kush Ruparelia, et al.Expert Review of Gastroenterology & Hepatology|April 12, 2011
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver diseaseAnn K Daly, Stefano Ballestri, Lucia Carulli, et al.Clinical Epigenetics|April 11, 2015
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver diseaseMüjdat Zeybel, Timothy Hardy, Stuart M Robinson, et al.Nature Communications|July 1, 2014
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver diseaseYang-Lin Liu, Helen L Reeves, Alastair D Burt, et al.Pageof 30